Seppo Salminen

Scientific Opinion on the substantiation of health claims related to very low calorie diets (VLCDs) and reduction in body weight (ID 1410), reduction in the sense of hunger (ID 1411), reduction in body fat mass while maintaining lean body mass (ID 1412), reduction of post-prandial glycaemic responses (ID 1414), and maintenance of normal blood lipid profile (1421) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J J ) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of a health claim related to zinc and “the prevention of bad breath by neutralising of volatile sulphur compounds in the mouth and oral cavity” pursuant to Article 13(5) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to coffee, including chlorogenic acids from coffee, and protection of DNA, proteins and lipids from oxidative damage (ID 1099, 3152, 4301), maintenance of normal blood glucose concentrations (ID 1100, 1962), and contribution to the maintenance or achievement of a normal body weight (ID 2031, 4326) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development (ID 501, 513, 540), maintenance of normal brain function (ID 497, 501, 510, 513, 519, 521, 534, 540, 688, 1323, 1360, 4294), maintenance of normal vision (ID 508, 510, 513, 519, 529, 540, 688, 2905, 4294), maintenance of normal cardiac function (ID 510, 688, 1360), “maternal health; pregnancy and nursing” (ID 514), “to fulfil increased omega-3 fatty acids need during pregnancy” (ID 539), “skin and digestive tract epithelial cells maintenance” (ID 525), enhancement of mood (ID 536), “membranes cell structure” (ID 4295), “anti-inflammatory action” (ID 4688) and maintenance of normal blood LDL-cholesterol concentrations (ID 4719) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to anthocyanins from Ribes nigrum L. and improvement of visual adaptation to the dark (ID 2750) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion Part I on the substantiation of health claims related to various food(s)/food constituent(s) not supported by pertinent human data (ID 411, 559, 1174, 1184, 1197, 1380, 1409, 1656, 1667, 1670, 1763, 1767, 1806, 1884, 1908, 1997, 2141, 2159, 2243, 2244, 2325, 2331, 2333, 2336, 2652, 2717, 2727, 2752, 2788, 2861, 2870, 2885, 2894, 3077, 3101, 3516, 3595, 3726, 4252, 4288, 4290, 4406, 4509, 4709) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to linoleic acid (LA) in combination with gamma-linolenic acid (GLA) and reduction of ocular dryness (ID 4274) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of a health claim related to ProteQuine® and increasing suppressed concentrations of secretory IgA and reducing the risk of influenza and common cold pursuant to Article 14 of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Scientific Opinion on the substantiation of health claims related to monomeric flavan-3-ols from apples and improvement of endothelium-dependent vasodilation (ID 1936) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Ota yhteyttä

Linkit

Asiantuntijuusalueet

Opetus

Tutkimus

Julkaisut

Järjestä:

Scientific Opinion on the substantiation of a health claim related to zinc and “the prevention of bad breath by neutralising of volatile sulphur compounds in the mouth and oral cavity” pursuant to Article 13(5) of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the substantiation of health claims related to anthocyanins from Ribes nigrum L. and improvement of visual adaptation to the dark (ID 2750) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the substantiation of health claims related to linoleic acid (LA) in combination with gamma-linolenic acid (GLA) and reduction of ocular dryness (ID 4274) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the substantiation of a health claim related to ProteQuine® and increasing suppressed concentrations of secretory IgA and reducing the risk of influenza and common cold pursuant to Article 14 of Regulation (EC) No 1924/2006 (2011)

Scientific Opinion on the substantiation of health claims related to monomeric flavan-3-ols from apples and improvement of endothelium-dependent vasodilation (ID 1936) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2011)